Some of the names on the move ahead of the open.» Read More
*Hologic up on Icahn stake, pares gain on shareholders rights plan. NEW YORK, Nov 21- U.S. stocks rose on Thursday after data pointed to a slowly improving labor market and subdued inflation, keeping intact most investors' expectations that the Federal Reserve is unlikely to scale back stimulus until early next year.
Nov 21- Activist investor Carl Icahn disclosed a 12.63 percent stake in medical device maker Hologic Inc, prompting the company to adopt a shareholder rights plan to protect itself from hostile takeovers. Shares of Hologic, which makes screening tests for cancer and other diseases, rose 3 percent in late morning trading.
Activist investor Carl Icahn reported a 12.63 stake in medical device maker Hologic, prompting the company to seek protection from a hostile takeover
*Hologic up on Icahn stake, pares gain on shareholders rights plan. NEW YORK, Nov 21- Wall Street was set to rise at the open on Thursday after data suggested stronger labor market conditions and subdued inflation pressures, while traders digested the Federal Reserve's latest assessment of the economy.
Nov 21- Activist investor Carl Icahn reported a 12.63 percent stake in medical device maker Hologic Inc, prompting the company to adopt a shareholder rights plan to protect itself from hostile takeovers.
U.S. stock index futures pointed to a mixed to higher open on Wall Street on Monday.
Delaware companies in advanced industries are bringing manufacturing jobs back from abroad, such as ILC Dover, and luring new ones from overseas, including Hologic from Germany.
Take a look at some of Thursday's midday movers:
"Two things usually send a stock higher: takeovers and breakups,” Cramer said. “This stock has the potential for both.”
Check out which companies are making headlines after the bell Tuesday:
The "Fast Money" traders share their final trades of the day.
It is shaping up to be the worst cold and flu season in about ten years, with more than 40 states reporting widespread influenza doctor visits and hospitalizations.
Oct 4- Diagnostic device maker Hologic Inc. said a U.S. district judge found that medical technology company Becton Dickinson& Co infringed on four patents owned by Hologic's unit Gen-Probe.
*Announces favorable ruling in litigation with Becton Dickinson,. *Favorable ruling in patent infringement litigation filed by unit against. *Court denied bd's summary judgment motion to dismiss gen-probe's infringement.
NEW YORK-- Analysts for Cowen and Co. started coverage of a group of companies that make tests used to diagnose infectious diseases, assigning top ratings to companies including Cepheid, Hologic Inc., and Meridian Bioscience Inc..
*Debt financing soars among larger medical device makers By Susan Kelly. CHICAGO, Oct 1- Venture capitalists, long the lifeblood of medical technology firms, are growing cautious on the sector after seeing their returns squeezed in a time of growing cost pressures for healthcare, a report by Ernst& Young said.
Stocks ended lower in thin trading Monday, with the S&P and the Nasdaq posting a loss for the month of April, following a handful of mixed economic reports in addition to news that Spain slipped into a recession.
CNBC's Seema Mody reports on which under the radar stocks are making big moves this afternoon, including Energy Transfer Partners' $5.3 billion deal to acquire Sunoco.
Shares of the following companies are showing unusual moves in Tuesday's trading session.
Hologic is surging 10 percent higher this week, with Robert Cascella, Hologic president & CEO.